Leads technology and product research and development. Martin has a master’s degree in Chemistry and a PhD in Chemical Biology, both from the University of Southampton and over 9 years R&D experience across academia and industry working at the interface of chemistry and biology. In 2015 he took up a post-doctoral research position in Synthetic Biology at the University of Bristol to lead the development of the Zentide technology and subsequently co-founded Zentraxa in 2017.
Harriet is responsible for conducting our research and development. She completed her undergraduate degree in Chemistry at the University of Bristol. During this time, she undertook a year in industry in Boston USA, designing peptide ligands for receptors over expressed on cancer cells. This experience inspired her to complete her PhD which she completed at the University of Bristol under the supervision of Prof. Dek Woolfson. Her PhD work focused on the design and characterisation of peptide-based biomaterials.
Dr Paul RaceDirector and Co-founder
Paul is Senior Lecturer in Biochemistry at the University of Bristol. From 2014-17 he served as Co-Director of the >£14M Bristol Centre for Synthetic Biology Research (BrisSynBio), was a founding Director of the Bristol BioDesign Institute (BBI) and is academic lead for the >£2.7M EPSRC funded ‘Manufacturing Immortality’ project. His research focuses on the exploitation and manipulation of biological complexes, pathways and networks, en-route to the development of new tools, technologies and products for biotechnology.
Dr Steve BurstonDirector and Co-founder
Steve completed his PhD in physical biochemistry at the University of Bristol before being awarded a Prize Fellowship from the Wellcome Trust to work at Yale University and the University of London. He then returned to the University of Bristol where he is a Principal Investigator in the School of Biochemistry.
Ms Jaci BarnettRTTP; Manager
Manages finances and governance. Jaci has a master’s degree in Chemical Engineering from the University of Natal, Durban, and an MBA from the University of Pretoria, South Africa. She worked in R&D management for over 10 years and has over 13 years’ experience in innovation management and technology transfer. She is currently the Senior Investment and Commercialisation Manager in the Research and Enterprise Division at the University of Bristol. She has worked with many university spin-off companies in both Non-Executive and Executive Director roles.
Nicolette undertook an undergraduate in Biochemistry and a PhD in Functional Nanomaterials, both at the University of Bristol. In 2017, she worked full time for Zentraxa, leading the materials testing R&D, before taking up a post-doctoral position in Synthetic Biology under the supervision of Dr. Paul Race.